Related Experiment Video
Updated: Jul 14, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
[A case of acute disseminated encephalomyelitis (ADEM) associated with peripheral neuropathy]
Nobuko Shiraiwa1, Toshihiro Yoshizawa, Norio Ohkoshi
1Department of Neurology, Tsukuba Memorial Hospital, University of Tsukuba.
Abstract:
A 17-year-old boy with high fever, headache, and neck stiffness was admitted to our hospital. Spinal fluid showed a protein level of 215 mg/dL with myelin basic protein (579 pg/mL), 347/ microl cells (330 mononuclear cells), and a glucose level of 53 mg/dL. One week later, urinary retention, flaccid paraplegia, and sensory disturbance below the 10th thoracic level developed. MRI of the spinal cord revealed swelling and T2-high intensity area in the cord at the 11th and 12th thoracic level. Although high-dose of methylprednisolone was administered, consciousness disturbance and respiratory failure that required mechanical ventilation occurred. Bilateral abducens nerve palsy, nystagmus, and flaccid tetraparesis also occurred. Brain MRI revealed T2-high intensity area in the midbrain and pons. Nerve conduction study showed diminished amplitudes and prolonged latencies or absence of F waves. The patient was administered a combination of intravenous immunoglobulin and a high-dose of methylprednisolone. He showed improvement within one week after the treatment. Two weeks later, he recovered from respiratory failure and weakness of the upper limbs. He remained paraplegic, but gradually improved and was able to walk with support one and a half years later. We suggest the combination therapy of intravenous immunoglobulin and a high-dose of methylprednisolone is effective for patients with combined ADEM and peripheral neuropathy.
Insights
This study presents a case of a 17-year-old boy with acute disseminated encephalomyelitis (ADEM) and peripheral neuropathy. Combined treatment with intravenous immunoglobulin and high-dose methylprednisolone showed significant improvement in neurological symptoms.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Acute disseminated encephalomyelitis (ADEM) is a rare, immune-mediated inflammatory demyelinating disease of the central nervous system.
- Peripheral neuropathy can sometimes co-occur with ADEM, presenting complex diagnostic and therapeutic challenges.
Observation:
- A 17-year-old male presented with fever, headache, and neck stiffness, progressing to paraplegia, urinary retention, and cranial nerve palsies.
- Cerebrospinal fluid analysis revealed elevated protein and mononuclear cells.
- Brain and spinal cord MRI showed demyelinating lesions consistent with ADEM, while nerve conduction studies indicated peripheral neuropathy.
Findings:
- Initial treatment with high-dose methylprednisolone alone did not prevent neurological deterioration, including respiratory failure.
- Combination therapy with intravenous immunoglobulin and high-dose methylprednisolone led to rapid clinical improvement within one week.
- The patient showed recovery from respiratory failure and upper limb weakness, with gradual improvement in lower limb function over 18 months.
Implications:
- Combined ADEM and peripheral neuropathy is a treatable neurological condition.
- Intravenous immunoglobulin combined with high-dose methylprednisolone may be an effective therapeutic strategy for this combined presentation.
- Early recognition and aggressive multimodal treatment are crucial for optimizing outcomes in patients with severe ADEM and coexisting peripheral neuropathy.
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Arboviral Encephalitis
Diphtheria
Multiple Sclerosis l: Introduction
Diabetic Neuropathy